Cargando…
Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction
Nine years elapsed between Gavi’s investment decision to support typhoid conjugate vaccines (TCVs) in 2008 and Gavi support becoming available for countries to introduce TCV. The protracted path toward Gavi support for TCV highlights the challenges of vaccine development for lower-income countries a...
Autores principales: | Soble, Adam, Patel, Zeenat, Sosler, Stephen, Hampton, Lee, Johnson, Hope |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388709/ https://www.ncbi.nlm.nih.gov/pubmed/32725236 http://dx.doi.org/10.1093/cid/ciaa342 |
Ejemplares similares
-
Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward
por: Russell, Allyson L, et al.
Publicado: (2023) -
Introduction of Typhoid Conjugate Vaccines in Africa and Asia
por: Neuzil, Kathleen M, et al.
Publicado: (2019) -
Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction
por: Carey, Megan E, et al.
Publicado: (2019) -
How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever
in Africa Programs Contribute to the Introduction of Typhoid Conjugate
Vaccines?
por: Jeon, Hyon Jin, et al.
Publicado: (2019) -
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
por: Bilcke, Joke, et al.
Publicado: (2019)